Tobacco Harm Reduction as a Path to Restore Trust in Tobacco Control [PDF]
International Journal of Environmental Research and Public Health, 2021 The controversy of tobacco harm reduction in the United States persists despite evidence that an important audience of tobacco prevention and control, i.e., the people who use or are likely to use nicotine and tobacco products, are engaging in practices ...
Tamar M J Antin +2 more
exaly +8 more sources
Tobacco harm reduction in Afghanistan: a recipe for improving smokers’ health [PDF]
Substance Abuse Treatment, Prevention, and Policy, 2023 Tobacco Harm Reduction (THR) offers a promising approach to addressing the significant burden of smoking in Afghanistan. Over three million Afghans smoke daily, making it a leading cause of preventable deaths in the country.
Attaullah Ahmadi +4 more
doaj +3 more sources
Tobacco harm reduction: Past history, current controversies and a proposed approach for the future [PDF]
Preventive Medicine, 2020 Tobacco harm reduction remains a controversial topic in tobacco control. Tobacco harm reduction involves providing tobacco users who are unwilling or unable to quit using nicotine products with less harmful nicotine-containing products for continued use.
Dorothy K Hatsukami, Dana Mowls Carroll
exaly +3 more sources
Advancing New Approach Methodologies (NAMs) for Tobacco Harm Reduction: Synopsis from the 2021 CORESTA SSPT—NAMs Symposium [PDF]
Toxics, 2022 New approach methodologies (NAMs) are emerging chemical safety assessment tools consisting of in vitro and in silico (computational) methodologies intended to reduce, refine, or replace (3R) various in vivo animal testing methods traditionally used for ...
Kyeonghee Monica Lee +6 more
doaj +3 more sources
Literacy among tobacco users and healthcare professionals about tobacco harm reduction strategies: a scoping review protocol [PDF]
Frontiers in Public HealthObjectiveThe proposed review identifies and describes the extent of Tobacco Harm Reduction (THR) strategies in Pakistan. It also examines the awareness and understanding of these strategies among healthcare professionals and tobacco users in Pakistan ...
Sajid Iqbal +4 more
doaj +4 more sources
Tobacco harm reduction in the 21st century [PDF]
Drugs and Alcohol Today, 2020 Purpose This paper aims to overview the need for tobacco harm reduction, the consumer products that facilitate tobacco harm reduction and the barriers to its implementation.
Renee O'Leary, Riccardo Polosa
exaly +3 more sources
Non-inferiority trial comparing cigarette consumption, adoption rates, acceptability, tolerability, and tobacco harm reduction potential in smokers switching to Heated Tobacco Products or electronic cigarettes: Study protocol for a randomized controlled trial [PDF]
Contemporary Clinical Trials Communications, 2020 Background: Despite the introduction of tobacco control measures, smoking remains highly prevalent in most EU countries. In Italy, one in four adults were still regular smokers in 2017.
Pasquale Caponnetto +12 more
doaj +3 more sources
What is the value of peer involvement in advancing tobacco harm reduction? [PDF]
Harm Reduction Journal, 2019 E-cigarettes are considered a disruptive technology [1], evidencing rapid growth in the financial market and attracting a distinct new customer base of would-be quitters, especially in Great Britain and the USA.
Caitlin Notley +3 more
doaj +3 more sources
The New Nicotine Pouch Category: A Tobacco Harm Reduction Tool? [PDF]
Nicotine Tob Res, 2022 Nicotine pouches to be put under the upper lip are a new category of products that are being rapidly developed and marketed as consumer goods with little research or regulatory oversight.
Patwardhan S, Fagerström K.
europepmc +2 more sources
Influence of Disclosed and Undisclosed Funding Sources in Tobacco Harm Reduction Discourse: A Social Network Analysis. [PDF]
Nicotine Tob Res, 2023 INTRODUCTION Tobacco harm reduction (THR) discourse has been divisive for the tobacco control community, partially because it sometimes aligns public health and tobacco industry interests.
Vassey J, Hendlin YH, Vora M, Ling P.
europepmc +2 more sources